RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

STIFEL FINANCIAL CORP's Holding History (CIK: 0000720672)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 590,148 Value ($000) $2,414 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 442,795 Value ($000) $2,161 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 256,092 Value ($000) $1,296 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 187,259 Value ($000) $991 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 159,887 Value ($000) $1,081 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 161,978 Value ($000) $1,067 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 108,875 Value ($000) $817 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 44,409 Value ($000) $443 Avg Close $11.14 Range $8.68 - $15.74

Q4 2023

Shares 27,189 Value ($000) $268 Avg Close $7.13 Range $4.97 - $11.17

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	590,148	$2,414	$4.95	$3.81 - $7.18
Q3 2025	442,795	$2,161	$5.25	$4.45 - $7.15
Q2 2025	256,092	$1,296	$4.91	$3.79 - $6.11
Q1 2025	187,259	$991	$7.29	$5.19 - $12.36
Q4 2024	159,887	$1,081	$6.72	$5.60 - $9.55
Q3 2024	161,978	$1,067	$7.17	$5.88 - $8.73
Q2 2024	108,875	$817	$8.72	$6.75 - $10.66
Q1 2024	44,409	$443	$11.14	$8.68 - $15.74
Q4 2023	27,189	$268	$7.13	$4.97 - $11.17